ES423856A1 - Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino. - Google Patents

Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.

Info

Publication number
ES423856A1
ES423856A1 ES423856A ES423856A ES423856A1 ES 423856 A1 ES423856 A1 ES 423856A1 ES 423856 A ES423856 A ES 423856A ES 423856 A ES423856 A ES 423856A ES 423856 A1 ES423856 A1 ES 423856A1
Authority
ES
Spain
Prior art keywords
delayed release
pharmaceutical preparations
release pharmaceutical
active substance
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES423856A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLYCLO IBE S A
Original Assignee
CLYCLO IBE S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLYCLO IBE S A filed Critical CLYCLO IBE S A
Publication of ES423856A1 publication Critical patent/ES423856A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES423856A 1973-12-06 1974-03-04 Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino. Expired ES423856A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732360796 DE2360796B2 (de) 1973-12-06 1973-12-06 Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm

Publications (1)

Publication Number Publication Date
ES423856A1 true ES423856A1 (es) 1976-05-01

Family

ID=5900064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES423856A Expired ES423856A1 (es) 1973-12-06 1974-03-04 Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.

Country Status (11)

Country Link
US (1) US4013784A (OSRAM)
JP (1) JPS5089521A (OSRAM)
AR (1) AR204629A1 (OSRAM)
BE (1) BE811175A (OSRAM)
DE (1) DE2360796B2 (OSRAM)
DK (1) DK137310C (OSRAM)
ES (1) ES423856A1 (OSRAM)
FR (1) FR2253508B1 (OSRAM)
GB (1) GB1427677A (OSRAM)
NL (1) NL7407233A (OSRAM)
SE (1) SE7407537L (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
EP0345628B1 (en) * 1988-06-07 1993-05-12 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US6207199B1 (en) 1994-01-27 2001-03-27 The Board Of Regents Of The University Of Oklahoma Process for making a particulate support matrix for making a rapidly dissolving dosage form
US6177104B1 (en) 1994-01-27 2001-01-23 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving dosage form
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US6187337B1 (en) 1994-01-27 2001-02-13 The Board Of Regents Of The University Of Oklahoma Rapidly dissolving dosage form
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10300325A1 (de) * 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US6992772B2 (en) * 2003-06-19 2006-01-31 Optix Lp Method and apparatus for optical sampling to reduce interfering variances
WO2005000237A2 (en) * 2003-06-25 2005-01-06 University Of Tennessee Research Foundation Granules containing biologically active substances
US20070082027A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
DE102013106998A1 (de) 2013-07-03 2015-01-08 Thyssenkrupp Industrial Solutions Ag Verfahren sowie eine Vorrichtung zur Herstellung einer Tablette
US10647045B1 (en) * 2016-11-03 2020-05-12 Specialty Earth Sciences, Llc Shaped or sized encapsulated reactant and method of making

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet

Also Published As

Publication number Publication date
DK137310B (da) 1978-02-20
BE811175A (fr) 1974-06-17
AR204629A1 (es) 1976-02-20
DK137310C (da) 1978-07-24
DK303974A (OSRAM) 1975-07-28
JPS5089521A (OSRAM) 1975-07-18
FR2253508A1 (OSRAM) 1975-07-04
SE7407537L (OSRAM) 1975-06-09
DE2360796B2 (de) 1977-06-02
US4013784A (en) 1977-03-22
DE2360796A1 (de) 1975-06-12
FR2253508B1 (OSRAM) 1977-11-10
NL7407233A (nl) 1975-06-10
GB1427677A (en) 1976-03-10

Similar Documents

Publication Publication Date Title
ES423856A1 (es) Procedimiento para la elaboracion de medicamentos con ce- sion retardada de la sustancia activa en el instestino.
ES435500A1 (es) Un procedimiento para la obtencion de un preparado terapeu- tico solido.
IL45160A (en) Peptides which inhibit release of growth hormone, their prduction and pharmaceutical compositions containing them
EG11468A (en) Process for the preparation of sulphoxides and pharmaceutical compositions comprising them
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
IL45675A (en) 6,8-dialkyl-7-alkoxycarbonyl-4-hydroxymethyl phthylazones and furo(3,4-f)phthalazine diones, their preparation and pharmaceutical compositions containing them
IL45685A (en) Process for the preparation of amino sugar compounds,certain new such compounds and pharmaceutical compositions containing them
GB1204580A (en) Pharmaceutical dosage forms
IL45880A (en) 3-phenyl-1,2-benzisoxyzole derivatives,their preparation and pharmaceutical compositions containing them
CA997677A (en) Layered bolus for animal husbandry providing for immediate and sustained release of medicament
ES357508A1 (es) Procedimiento de preparacion de colageno degradado.
ZA723387B (en) New oxadiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
ES399609A1 (es) Procedimiento para la fabricacion de un polvo de producto lacteo acidificado.
IL39147A0 (en) New amino alcohols derived from ortho trans-hydroxycinnamic acids,their esters and their amides,preparation thereof and pharmaceutical compositions containing them
IL40457A0 (en) New esters and salts of oburnamine type alkaloids,their preparation and pharmaceutical compositions containing them
IL40685A0 (en) Pharmaceutical compositions for the dissolution of renal calculi and their preparation
ES297425A1 (es) Procedimiento para preparar composiciones farmaceúticas en forma de tabletas de acción diferida
GB630439A (en) Improvements in or relating to pharmaceutical preparations
ES332215A1 (es) Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta.
ATA401872A (de) Bildmischschaltung
ES406781A1 (es) Procedimiento para la fabricacion de sustancias activas pulverizadas protegidas contra un medio biologico.
ES324708A1 (es) Un metodo de preparar composiciones farmaceuticas y veterinarias.
ES361494A1 (es) Procedimiento para la preparacion de medicamentos con libe-racion prolongada de la sustancia activa.
ES244907A3 (es) Nuevo procedimiento para fabricar farmacos de acciën inmediata y retardada
HU172254B (hu) Stacionarnoe oborudovanie dlja nepreryvnogo raspredelenija vsasyvaemogo korma dlja zhivotnykh